|
1
|
Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome.
|
Am J Respir Crit Care Med
|
2001
|
2.68
|
|
2
|
New deal for old hearts.
|
BMJ
|
1991
|
1.90
|
|
3
|
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
|
Circulation
|
1999
|
1.79
|
|
4
|
A 'same day' direct-access chest pain clinic: improved management and reduced hospitalization.
|
QJM
|
1998
|
1.77
|
|
5
|
Measurement of specific [3H]-ouabain binding to different types of human leucocytes.
|
Br J Clin Pharmacol
|
1984
|
1.56
|
|
6
|
Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation?
|
Eur Heart J
|
2013
|
1.55
|
|
7
|
Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.
|
Heart
|
2006
|
1.55
|
|
8
|
Aortic valve calcification on computed tomography predicts the severity of aortic stenosis.
|
Clin Radiol
|
2003
|
1.52
|
|
9
|
Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations.
|
Eur Heart J
|
2002
|
1.52
|
|
10
|
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
|
Lancet
|
2002
|
1.46
|
|
11
|
Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.
|
Cardiovasc Res
|
2000
|
1.43
|
|
12
|
Hyperinsulinaemia in ischaemic heart disease: the importance of myocardial infarction and left ventricular function.
|
Q J Med
|
1994
|
1.39
|
|
13
|
Heart muscle disease related to HIV infection: prognostic implications.
|
BMJ
|
1994
|
1.37
|
|
14
|
Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leucocytes.
|
Clin Sci (Lond)
|
1985
|
1.34
|
|
15
|
Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis.
|
Circulation
|
2001
|
1.32
|
|
16
|
Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide.
|
Clin Sci (Lond)
|
1997
|
1.27
|
|
17
|
Thyroid disease and the heart.
|
Heart
|
2000
|
1.18
|
|
18
|
A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine.
|
J Auton Pharmacol
|
1983
|
1.15
|
|
19
|
A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing.
|
Br Heart J
|
1987
|
1.11
|
|
20
|
Enhancement of specific [3H]ouabain binding and ouabain sensitive 86rubidium influx in intact human lymphocytes by a dialysable factor in human and fetal calf serum.
|
Clin Sci (Lond)
|
1987
|
1.10
|
|
21
|
A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection.
|
Eur Heart J
|
1995
|
1.07
|
|
22
|
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems.
|
Cardiovasc Res
|
1998
|
1.04
|
|
23
|
Myocardial dysfunction in patients infected with HIV: prevalence and risk factors.
|
Br Heart J
|
1992
|
1.02
|
|
24
|
Dietary salt and hypertension: treatment and prevention.
|
Br Med J (Clin Res Ed)
|
1985
|
1.02
|
|
25
|
Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.
|
Br J Clin Pharmacol
|
1997
|
1.01
|
|
26
|
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease.
|
Heart
|
2005
|
1.01
|
|
27
|
An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.
|
Thromb Haemost
|
1997
|
1.00
|
|
28
|
Cardiac autoimmunity in HIV related heart muscle disease.
|
Heart
|
1998
|
1.00
|
|
29
|
Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?
|
Heart
|
2006
|
0.99
|
|
30
|
Cation transport abnormalities in vivo in untreated essential hypertension.
|
Clin Sci (Lond)
|
1986
|
0.98
|
|
31
|
A method for the study of cation transport in vivo: effects of digoxin administration and of chronic renal failure on the disposition of an oral load of rubidium chloride.
|
Clin Sci (Lond)
|
1984
|
0.97
|
|
32
|
Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease.
|
Platelets
|
2006
|
0.97
|
|
33
|
Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy?
|
Clin Cardiol
|
2001
|
0.95
|
|
34
|
HIV cardiomyopathy: a dark cloud with a silver lining?
|
Br Heart J
|
1991
|
0.90
|
|
35
|
Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
|
J Am Coll Cardiol
|
2001
|
0.89
|
|
36
|
In vivo cation transport during short-term and long-term digoxin therapy.
|
Br J Clin Pharmacol
|
1986
|
0.87
|
|
37
|
A sensitive high-temperature electrothermal atomic absorption analysis for Rb+ in erythrocytes and plasma of normal and hypertensive persons.
|
Clin Chem
|
1985
|
0.87
|
|
38
|
Head-up tilt testing. The balance of evidence.
|
Br Heart J
|
1994
|
0.86
|
|
39
|
Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X.
|
J Am Coll Cardiol
|
1998
|
0.86
|
|
40
|
Multiple neoplasia in a patient on dialysis presenting with haematuria.
|
Br J Urol
|
1984
|
0.86
|
|
41
|
Effects of dual-chamber pacing in hypertrophic cardiomyopathy without obstruction.
|
Lancet
|
1992
|
0.86
|
|
42
|
Enalapril overdose and the corrective effect of intravenous angiotensin II.
|
Br J Clin Pharmacol
|
1995
|
0.86
|
|
43
|
Cardiac involvement in human immunodeficiency virus infection.
|
Q J Med
|
1993
|
0.85
|
|
44
|
Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats.
|
Heart
|
1996
|
0.84
|
|
45
|
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
|
Eur J Heart Fail
|
1999
|
0.84
|
|
46
|
Successful balloon dilatation of the pulmonary valve in carcinoid heart disease.
|
Int J Cardiol
|
1994
|
0.83
|
|
47
|
Solvent abuse and the heart.
|
Br Med J (Clin Res Ed)
|
1987
|
0.83
|
|
48
|
Indications for pulmonary embolectomy.
|
Lancet
|
1988
|
0.83
|
|
49
|
Incidence and significance of rising blood acetate levels during hemodialysis.
|
Clin Nephrol
|
1979
|
0.82
|
|
50
|
Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition.
|
Eur Heart J
|
1998
|
0.82
|
|
51
|
Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.
|
Cardiovasc Res
|
1997
|
0.81
|
|
52
|
The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man.
|
Cardiovasc Res
|
1998
|
0.81
|
|
53
|
Immediate coronary angioplasty for acute myocardial infarction.
|
BMJ
|
1993
|
0.81
|
|
54
|
Transvenous pacemaker electrodes placed unintentionally in the left ventricle: three cases.
|
Postgrad Med J
|
1989
|
0.79
|
|
55
|
Atrial pacing: who do we pace and what do we expect? Experiences with 100 atrial pacemakers.
|
Pacing Clin Electrophysiol
|
1990
|
0.79
|
|
56
|
Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.
|
Heart
|
1998
|
0.79
|
|
57
|
Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.
|
Heart
|
2002
|
0.78
|
|
58
|
Support ventilation versus conventional oxygen.
|
Lancet
|
2001
|
0.78
|
|
59
|
Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation.
|
Clin Sci (Lond)
|
2001
|
0.78
|
|
60
|
Effects of abstinence on alcoholic heart muscle disease.
|
Am J Cardiol
|
1991
|
0.77
|
|
61
|
Platelet alpha-adrenoreceptors in borderline and established essential hypertension.
|
Clin Sci (Lond)
|
1983
|
0.77
|
|
62
|
Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three?
|
Heart
|
2002
|
0.77
|
|
63
|
Effect of cardiac tamponade on atrial natriuretic peptide concentrations: influence of stretch and pressure.
|
Clin Sci (Lond)
|
1990
|
0.77
|
|
64
|
Early vasodilator treatment in myocardial infarction: appropriate for the majority or minority?
|
Br Heart J
|
1992
|
0.76
|
|
65
|
Dilated cardiomyopathy in haemophiliacs infected with the human immunodeficiency virus.
|
Scott Med J
|
1993
|
0.76
|
|
66
|
A century of cardiac pacing.
|
BMJ
|
1989
|
0.75
|
|
67
|
Psoriasis developing during dialysis.
|
Br Med J
|
1979
|
0.75
|
|
68
|
Lower cardiac mortality in smokers following thrombolysis.
|
QJM
|
1999
|
0.75
|
|
69
|
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
|
Eur J Clin Pharmacol
|
1994
|
0.75
|
|
70
|
Cardiac dysfunction in paediatric HIV infection.
|
J Infect
|
1993
|
0.75
|
|
71
|
Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans.
|
Clin Pharmacol Ther
|
1997
|
0.75
|
|
72
|
Effects of haemodialysis and continuous ambulatory peritoneal dialysis on abnormalities of ion transport in vivo in patients with chronic renal failure.
|
Clin Sci (Lond)
|
1993
|
0.75
|
|
73
|
An in vivo study of cation transport in essential hypertension.
|
J Hypertens Suppl
|
1984
|
0.75
|
|
74
|
Long-term survival following pericardiectomy for Staphylococcus aureus pericarditis in an HIV-positive drug user.
|
Eur Heart J
|
1997
|
0.75
|
|
75
|
Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease.
|
J Thromb Haemost
|
2006
|
0.75
|
|
76
|
Long-term clinical safety and efficacy of NIROYAL vs. NIR intracoronary stent.
|
Catheter Cardiovasc Interv
|
2001
|
0.75
|